July 2007

Diabetes and Lipids

Anti-inflammatory effects of pioglitazone and/or simvastatin in patients with distinct clinical risk for cardiovascular complications

by Markolf Hanefeld, MD, PhD • Thomas Forst, MD

From the Center for Clinical Studies, GWT-Technical University, Dresden and Institute for Clinical Research and Development, Mainz, Germany.

Commentary

One drug, so many off-target beneficial effects?

by Ira J. Goldberg, MD

CAD and Imaging

Myocardial perfusion imaging in identifying a low-risk group after acute myocardial infarction

by John J. Mahmarian, MD • Craig M. Pratt, MD

From the Methodist DeBakey Heart Center, Department of Cardiology, The Methodist Hospital, Houston, Texas.

Commentary

Assessing risk through "inspired" care

by Steven Borzak, MD

Heart Failure and Arrhythmias

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

by Salam Sbaity • Pamela Nerheim • Brian Olshansky, MD1

From the Division of Cardiology, University of Iowa Hospitals and Clinics, Iowa City,

Hypertension

Primary aldosteronism in hypertensive patients

by Gian Paolo Rossi, MD for the PAPY Study Investigators

From the Padova DMCS Internal Medicine, Padova, Italy.

Commentary

Screening for primary aldosteronism

by Samuel J. Mann, MD

Alcohol and hypertension

by Arthur L. Klatsky, MD

From the Department of Cardiology, Kaiser Permanente Medical Care Program, Kaiser Permanente Medical Center, Oakland, California.

Commentary

Uncorking new evidence in the alcohol-hypertension relationship

by Nobuyuki (Bill) Miyawaki, MD • John K. Maesaka, MD

Departments

	Editor's Page
	Doubling up cardiology coverage
	by Peter F. Cohn, MD


	Letters to the Editor


	News from the ABC
	Leave later: children should know their grandparents


	Newsbeat
	News from the 22nd Annual Scientific Meeting of the American Society of Hypertension, Chicago, May 19-22, 2007


	CME Questions